34.3% Below Target

The consensus Wall Street price target for INMD is $18, representing 34.3% upside from the current price of $13.4. With 11 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

INMD has a consensus rating of "Hold" based on 11 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $18 implies 34.3% upside from current levels.

With a forward P/E of 10.0247x, INMD trades at a relatively low valuation. The consensus target of $18 implies 34.3% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $19 for INMD, while the most conservative target is $17. The consensus of $18 represents the median expectation. Our quantitative valuation model projects a bull case target of $28 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

INMD is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 6 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month INMD stock forecast based on 11 Wall Street analysts shows a consensus price target of $18, with estimates ranging from $17 (bear case) to $19 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $21, with bear/bull scenarios of $13/$28.

Our quantitative valuation model calculates INMD's fair value at $21 (base case), with a bear case of $13 and bull case of $28. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.

INMD trades at a forward P/E ratio of 10.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 9.4x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on INMD, with a "Hold" consensus rating and $18 price target (34.3% upside). 5 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

INMD analyst price targets range from $17 to $19, a 11% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18 consensus represents the middle ground. Our model's $13-$28 range provides an independent fundamental perspective.